Project Grant DP2DA066177
Award Date 5/1/26
Completion Date 4/30/30
Dollars Obligated $2.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Roxbury, MA 02118, USA
Similar Awards
- Federal Grant Award Summary Boston Medical Center Corporation received a $356,630 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 1, 2025, with completion scheduled for August 31, 2027. The grant supports immune profiling research investigating how drug abuse impacts antibody responses in people living with HIV (PLWH), particularly among people who use substances and live with HIV (PWUSH). The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH), effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year research initiative will deliver clinical outcomes research and health economic analysis focused on integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston University Medical Campus $2.9 million under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and optimize a multicomponent behavioral intervention designed to improve buprenorphine treatment retention for individuals with opioid use disorder. The project, titled "BUP-BOOSTER: Behavioral Optimization for Overcoming Suboptimal Treatment Retention," will recruit 240 patients...
- Federal Project Grant Award Summary Boston Medical Center Corporation received a $269,394 project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 15, 2025, with completion targeted for June 30, 2030. The Clinical Undergraduate Research in Addictions – Training and Experiences (CURATE) Program develops and delivers a 10-week summer research training initiative designed to increase the pipeline of undergraduate...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $1.74 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on July 15, 2025, with a completion date of March 31, 2030. This award funds research to discover and functionally characterize long non-coding RNAs (lncRNAs) in opioid use disorder (OUD) within the context of HIV at single-cell resolution. The project addresses a...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.5 million Project Grant to the University of Massachusetts Medical School on September 1, 2025, to conduct the "Improving Access to Medications for Opioid Use Disorder (MOUD) in Drug Courts Through Inter-Agency Collaboration: COLAAB Study" under the Drug Use and Addiction Research Programs (CFDA 93.279). The five-year project, concluding May 31, 2030, implements and evaluates a package of...
- Federal Grant Award Summary Brigham and Women's Hospital Inc. received a $557,105 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to design, implement, and evaluate community-wide Public Access Naloxone (PAN) programs. The award, effective April 1, 2026 through March 31, 2028, supports a phased approach consisting of a planning phase (R61) and an implementation phase (R33). During the planning phase, the project will...
- Federal Grant Award Summary New York University School of Medicine received a $771,043 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, through December 31, 2030. The grant supports a hybrid Type II implementation-effectiveness trial of the LINKED (Leveraging Interpersonal Networks to Keep Engagement in PrEP & MOUD) intervention, a peer-driven social network program designed to increase...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $3.097 million Project Grant effective September 1, 2025, through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct "Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes." The project addresses the critical gap in medication for...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston College $941,917 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025, for a two-year project period concluding August 31, 2027. The award funds a cluster-randomized controlled trial implementing the Worker Input and Strategy Program (WISP), an evidence-based participatory organizational intervention designed to address workforce challenges in residential addiction treatment...